Search Results - "Hegerova, L."

Use of the IL‐6R antagonist tocilizumab in hospitalized COVID‐19 patients by Patel, K., Gooley, T. A., Bailey, N., Bailey, M., Hegerova, L., Batchelder, A., Holdread, H., Dunleavy, V., Downey, T., Frisvold, J., Megrath, S., Pagarigan, K., Szeto, J., Rueda, J., Islam, A., Maree, C., Nyatsatsang, S., Bork, S. E., Lipke, A., O’Mahony, D. S., Wagner, T., Pulido, J., Mignone, J., Youssef, S., Hartman, M., Goldman, J. D., Pagel, J. M.

Get full text

Improving outcomes after allogeneic hematopoietic cell transplantation for Hodgkin lymphoma in the brentuximab vedotin era by Hegerova, L, Cao, Q, Lazaryan, A, McClune, B L, Weisdorf, D J, Brunstein, C G, Bachanova, V

“…Allogeneic hematopoietic cell transplantation (alloHCT) remains a valuable treatment alternative for relapsed/refractory (R/R) Hodgkin lymphoma (HL). Data on…”
Get full text